Cancer Screening and Prevention Program for High Risk Women
2 other identifiers
observational
1,452
1 country
3
Brief Summary
The purpose of this study is to collect information from a large group of women who may have a greater chance to develop cancer because of their own personal history of cancer or because of their family history of cancer.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jul 2001
Longer than P75 for all trials
3 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 1, 2001
CompletedFirst Submitted
Initial submission to the registry
February 20, 2009
CompletedFirst Posted
Study publicly available on registry
February 23, 2009
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
January 1, 2018
CompletedMay 6, 2020
May 1, 2020
16.5 years
February 20, 2009
May 4, 2020
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
To create a registry for women at high risk of breast or ovarian cancer
15 years
Secondary Outcomes (1)
To provide genetic counseling, referrals for diagnostic tests and to appropriate clinics to promote the early detection of cancer; to seek and develop research protocols of early detection and treatment
15 years
Study Arms (1)
High risk of breast or ovarian cancer
Eligibility Criteria
Primarily disadvantaged women who have a family history of breast and or ovarian cancer or who have had a personal history of breast and or ovarian cancer or who themselves or a relative have positive genetic markers for breast or ovarian cancer.
You may qualify if:
- Female or male over the age of 18.
- Patients who have a family history of breast and or ovarian cancer.
- Patients who have had a personal history of breast and or ovarian cancer or who themselves or a relative have positive genetic markers for breast or ovarian cancer.
- Patients who seek medical screening and risk assessment for perceived increased risk of breast or ovarian cancer.
You may not qualify if:
- Women with psychiatric, psychological or other conditions which prevent fully informed consent.
- Patients seeking medical attention not related to the purposes of this protocol, (e.g. those seeking treatment of a known cancer).
- Women with a history of any medical condition, which places the subject at risk, related to the need for donating blood for research purposes, (e.g., chronic infectious diseases, severe anemia, or hemophilia).
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (3)
Bellevue Hospital
New York, New York, 10016, United States
NYU Cancer Center
New York, New York, 10016, United States
NYU Tisch Hospital
New York, New York, 10016, United States
Related Publications (1)
Smith J, Baer L, Blank S, Dilawari A, Carapetyan K, Alvear M, Utate M, Curtin J, Muggia F. A screening and prevention programme serving an ethnically diverse population of women at high risk of developing breast and/or ovarian cancer. Ecancermedicalscience. 2009;3:123. doi: 10.3332/ecancer.2008.123. Epub 2009 Mar 16.
PMID: 22275995RESULT
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Franco Muggia, MD
NYU Langone Health
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
February 20, 2009
First Posted
February 23, 2009
Study Start
July 1, 2001
Primary Completion
January 1, 2018
Study Completion
January 1, 2018
Last Updated
May 6, 2020
Record last verified: 2020-05